AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. COSMOS Pharmaceutical Corporation
  3. Financials
  4. Free cash flow

COSMOS Pharmaceutical Corporation【JP:3349】

Market cap
¥550.2B
P/E ratio
17.6x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndFree cash flow (Million JPY)YoY (%)
May 31, 2025-859+35.28%
May 31, 2024-635-108.14%
May 31, 20237,798-168.99%
May 31, 2022-11,303-724.13%
May 31, 20211,811-95.42%
May 31, 202039,513+640.08%
May 31, 20195,339+70.30%
May 31, 20183,135-62.10%
May 31, 20178,271-7902.83%
May 31, 2016-106-98.98%
May 31, 2015-10,411-278.94%
May 31, 20145,818

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)